The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InStryker Corporation (SYK) shares hit a 52-week low of 290.17 USD, representing a 21% retreat from its previous high of 404.87 USD. The decline is attributed to a cyberattack that caused a global manufacturing disruption lasting approximately three weeks, severely impacting Q1 2026 financial results. Consequently, the medical technology giant missed analyst estimates for both earnings per share (EPS) and total revenue. Despite the operational setback, the analyst consensus maintains a 'Moderate Buy' rating, suggesting long-term confidence in the company's recovery. Investors remain focused on Stryker's ability to mitigate the damage and restore market trust following the security breach. The situation highlights the significant impact that cybersecurity threats can have on global supply chains and mega-cap valuations.